We are live on
!
Find out more
BL
Bleichroeder LP Portfolio holdings
AUM
$559M
Turnover
17.24%
1-Year Est. Return
83.7%
This Fund
S&P 500
This Quarter
Est. Return
+13.86%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$450M
AUM Growth
+$44.2M
(+11%)
Cap. Flow
+$6.33M
Cap. Flow
% of AUM
1.41%
Top 10 Holdings %
Top 10 Hldgs %
82.16%
Holding
81
New
7
Increased
6
Reduced
2
Closed
4
Avg Time Held
2.6
years
Top 10 Avg Time Held
2.2
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
bluebird bio
BLUE
|
+$4.88M |
| 2 |
Cue Biopharma
CUE
|
+$2.38M |
| 3 |
Profound Medical
PROF
|
+$1.27M |
| 4 |
MDxHealth
MDXH
|
+$1.26M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DURECT Corp
DRRX
|
+$6.57M |
| 2 |
Yext
YEXT
|
+$274K |
| 3 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
+$11.1K |
| 4 |
EQRXW
EQRx, Inc. Warrant
EQRXW
|
+$8.02K |
| 5 |
Liberty Live Group Series C
LLYVK
|
+$68 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 20.98% |
| 2 | Miscellaneous | 20.63% |
| 3 | Healthcare | 20.15% |
| 4 | Industrials | 14.66% |
| 5 | Materials | 10.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Advanced Micro Devices
AMD
$918B
| $135K | 0.03% |
913
| – | – |
2022 Q1
7 quarters
|
|
52
Liberty Latin America Class C
LILAK
$1.6B
| $121K | 0.03% |
18,174
| – | – |
2020 Q2
14 quarters
|
|
53
ExxonMobil
XOM
$718B
| $107K | 0.02% |
1,075
| – | – |
2020 Q2
14 quarters
|
|
54
Bank of New York Mellon
BNY
$96.4B
| $104K | 0.02% |
2,000
| – | – |
2020 Q1
15 quarters
|
|
55
DELISTED
OppFi Inc Warrants
OPFI.WS
| $97.5K | 0.02% |
250,000
| – | – |
2021 Q3
9 quarters
|
|
56
AbbVie
ABBV
$501B
| $79.8K | 0.02% |
515
| – | – |
2020 Q2
14 quarters
|
|
57
Revolution Medicines Inc Warrant
RVMDW
$108M
| $66K | 0.01% |
+200,000
| New | +$89.3K |
2023 Q4
0 quarters
|
|
58
Teradyne
TER
$53.7B
| $65.1K | 0.01% |
600
| – | – |
2020 Q2
14 quarters
|
|
59
Altria Group
MO
$123B
| $48.4K | 0.01% |
1,200
| – | – |
2020 Q2
14 quarters
|
|
60
DELISTED
CompoSecure Inc Warrant
CMPOW
| $37.3K | 0.01% |
100,000
| – | – |
2022 Q1
7 quarters
|
|
61
Lumentum
LITE
$78.8B
| $34.6K | 0.01% |
660
| – | – |
2020 Q2
14 quarters
|
|
62
ARK Blockchain & Fintech Innovation ETF
ARKF
$912M
| $33.1K | 0.01% |
1,200
| – | – |
2022 Q1
7 quarters
|
|
63
Liberty Latin America Class A
LILA
$1.62B
| $29.4K | 0.01% |
5,913
| – | – |
2020 Q1
15 quarters
|
|
64
AT&T
T
$161B
| $27.7K | 0.01% |
1,650
| – | – |
2020 Q2
14 quarters
|
|
65
ARK Genomic Revolution ETF
ARKG
$2.09B
| $27.1K | 0.01% |
825
| – | – |
2022 Q1
7 quarters
|
|
66
ARK Next Generation Technology ETF
ARKW
$2.25B
| $22.8K | 0.01% |
300
| – | – |
2022 Q1
7 quarters
|
|
|
67
Revolution Medicines
RVMD
$40.6B
| $15.9K | ﹤0.01% |
+556
| New | +$13.4K |
2023 Q4
0 quarters
|
|
68
X4 Pharmaceuticals
XFOR
$262M
| $15K | ﹤0.01% |
596
| – | – |
2019 Q4
16 quarters
|
|
69
SaverOne 2014 Ltd Warrant
SVREW
$63.2K
| $14.5K | ﹤0.01% |
121,000
| – | – |
2022 Q2
6 quarters
|
|
70
DELISTED
Warner Bros
WBD
| $4.54K | ﹤0.01% |
399
| – | – |
2022 Q2
6 quarters
|
|
71
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
| $3.5K | ﹤0.01% |
971
| – | – |
2021 Q1
11 quarters
|
|
72
Aviat Networks
AVNW
$250M
| $2.16K | ﹤0.01% |
66
| – | – |
2020 Q2
14 quarters
|
|
|
SLGCW
73
DELISTED
SomaLogic, Inc. Warrant
SLGCW
| $1.68K | ﹤0.01% |
14,020
| – | – |
2021 Q2
10 quarters
|
|
74
Alliance Entertainment Holding Corp Warrants
AENTW
| $1.5K | ﹤0.01% |
200,000
| – | – |
2023 Q2
2 quarters
|
|
75
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $1.18K | ﹤0.01% |
517
| – | – |
2021 Q3
9 quarters
|
|
Similar funds
NFW
SCM
PHC
EPM
BCM
FAM
WDG
OC
Bleichroeder LP's Q4 2023 Portfolio in Review
As of Q4 2023, Bleichroeder LP held 81 positions worth $450M, up 11% from $406M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Bleichroeder LP's Q4 2023 filing shows 7 new, 6 increased, 2 reduced and 4 closed positions. Its largest new stake was Profound Medical: 133,333 shares worth $1.13M. The largest sale was DURECT Corp, an estimated $6.57M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bleichroeder LP's largest Q4 2023 buy was Profound Medical: 133,333 shares worth $1.13M.
- Bleichroeder LP added most to bluebird bio in Q4 2023, an estimated $4.88M increase.
- Bleichroeder LP's biggest Q4 2023 reduction was Liberty Live Group Series C, cutting an estimated $68.
- Bleichroeder LP fully exited DURECT Corp in Q4 2023, selling an estimated $6.57M.
- Bleichroeder LP's ten largest holdings make up 82% of its $450M portfolio in Q4 2023.
- Bleichroeder LP opened 7 new positions and closed 4 in Q4 2023.
- Bleichroeder LP's portfolio value rose 11% quarter-over-quarter to $450M.
Based on Bleichroeder LP's 13F filing for Q4 2023, filed 12 Feb 2024.